The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells

The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells

Bibliographic Details
Main Authors: Hirofumi Tenshin, Takeshi Harada, Yusuke Inoue, Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Kotaro Tanimoto, So Shimizu, Yoshiki Higa, Masahiro Oura, Kimiko Sogabe, Tomoyo Hara, Tomoko Maruhashi, Itsuro Endo, Toshio Matsumoto, Eiji Tanaka, Masahiro Abe
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Bone Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187221001571

Internet

http://www.sciencedirect.com/science/article/pii/S2352187221001571

Similar Items